Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Guelph

$17,500.00

Bdellovibrio-and-like Organisms and their Predatory Effectiveness against Colorectal Oncomicrobes

FY 2019-20

Summary
"Colorectal cancer (CRC) is a prevalent global malignancy with more than 1 million cases diagnosed every year. What is of more concern is that the age of onset is decreasing. Oncomicrobes, including Fusobacterium nucleatum (Fn), are microbes linked to the initiation/development of tumors. Eliminating these oncomicrobes from the colon may reduce the likelihood of developing colorectal cancer or slow disease progression. Targeting Fn with antibiotics risks damaging the human gut microbiome and the possibility of Fn and other bacteria developing antibiotic resistance. Instead, a biological antimicrobial agent can be explored; Bdellovibrio-and-like organisms (BALOs). BALOs are aerobic, predatory deltaproteobacteria that kill Gram-negative bacteria as a part of their life-cycle. I hypothesize that BALOs can effectively predate on Fn in such a manner that they can be considered for therapeutic use in the treatment of CRC.. I will investigate how BALOs, including Bdellovibrio bacteriovorus HD100, the type strain, are able to remove oncomicrobes from a variety of mixed bacterial communities that are representative of the human colon, restoring the colonic microbiome to a normally functioning state. My main objectives are to 1) isolate BALOs from the environment, 2) compare the predatory effectiveness of BALO isolates under different testing conditions, and 3) evaluate the predatory effectiveness of BALOs within a CRC colonic microbiome community using a bioreactor model. Using BALOs as a bacterial therapy against cancer-promoting oncomicrobes would be novel and could be promising for colorectal cancer research alongside current or other novel treatment methods to better patient outcomes."
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
428842
Name
Higgins Greg
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Bdellovibrio-and-like Organisms and their Predatory Effectiveness against Colorectal Oncomicrobes
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anaerobic Respiration; Bacterial Isolations; Bdellovibrio Bacteriovorus; Bdellovibrio-And-Like Organisms; Colorectal Cancer; Fusobacterium Nucleatum; Gut Microbial Diversity; Gut Microbiome; Oncomicrobes; Predation Assays
Abstract
"Colorectal cancer (CRC) is a prevalent global malignancy with more than 1 million cases diagnosed every year. What is of more concern is that the age of onset is decreasing. Oncomicrobes, including <em>Fusobacterium nucleatum</em> (<em>Fn</em>), are microbes linked to the initiation/development of tumors. Eliminating these oncomicrobes from the colon may reduce the likelihood of developing colorectal cancer or slow disease progression. Targeting <em>Fn</em> with antibiotics risks damaging the human gut microbiome and the possibility of <em>Fn </em>and other bacteria developing antibiotic resistance. Instead, a biological antimicrobial agent can be explored; <em>Bdellovibrio</em>-and-like organisms (BALOs). BALOs are aerobic, predatory deltaproteobacteria that kill Gram-negative bacteria as a part of their life-cycle. I hypothesize that BALOs can effectively predate on <em>Fn</em> in such a manner that they can be considered for therapeutic use in the treatment of CRC.. I will investigate how BALOs, including <em>Bdellovibrio bacteriovorus</em> HD100, the type strain, are able to remove oncomicrobes from a variety of mixed bacterial communities that are representative of the human colon, restoring the colonic microbiome to a normally functioning state. My main objectives are to 1) isolate BALOs from the environment, 2) compare the predatory effectiveness of BALO isolates under different testing conditions, and 3) evaluate the predatory effectiveness of BALOs within a CRC colonic microbiome community using a bioreactor model. Using BALOs as a bacterial therapy against cancer-promoting oncomicrobes would be novel and could be promising for colorectal cancer research alongside current or other novel treatment methods to better patient outcomes."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Higgins, Greg
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~